We are live on ! Find out more
NIM

NEOS Investment Management Portfolio holdings

AUM $27.1B
1-Year Est. Return 57.21%
This Fund
S&P 500
This Quarter Est. Return
+5.84%
1 Year Est. Return
+57.21%
3 Year Est. Return
+163.05%
5 Year Est. Return
10 Year Est. Return
AUM
$3.31B
AUM Growth
+$883M
Cap. Flow
+$750M
Cap. Flow %
22.66%
Top 10 Hldgs %
34.05%
Holding
588
New
19
Increased
513
Reduced
16
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 32.75%
2 Healthcare 12.38%
3 Communication Services 9.77%
4 Consumer Discretionary 9.17%
5 Industrials 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATI icon
151
ATI
ATI
$26B
$4.23M 0.13%
63,162
+23,166
+58% +$1.44M
FSS icon
152
Federal Signal
FSS
$6.96B
$4.2M 0.13%
44,979
+16,497
+58% +$1.51M
MO icon
153
Altria Group
MO
$117B
$4.2M 0.13%
82,350
+17,052
+26% +$862K
FLR icon
154
Fluor
FLR
$7.18B
$4.19M 0.13%
87,725
+32,175
+58% +$1.52M
DUK icon
155
Duke Energy
DUK
$92.3B
$4.09M 0.12%
35,484
+7,308
+26% +$813K
CTSH icon
156
Cognizant
CTSH
$28.3B
$4.08M 0.12%
52,849
+9,787
+23% +$729K
ODFL icon
157
Old Dominion Freight Line
ODFL
$36.8B
$4.06M 0.12%
20,453
+3,547
+21% +$690K
GEHC icon
158
GE HealthCare
GEHC
$28.8B
$4.02M 0.12%
42,829
+7,587
+22% +$637K
ZTS icon
159
Zoetis
ZTS
$30.3B
$3.94M 0.12%
20,167
+4,060
+25% +$748K
CHTR icon
160
Charter Communications
CHTR
$16.6B
$3.93M 0.12%
12,116
+1,893
+19% +$637K
MELI icon
161
Mercado Libre
MELI
$91.7B
$3.89M 0.12%
1,894
-42
-2% -$79.1K
CME icon
162
CME Group
CME
$98.4B
$3.85M 0.12%
17,441
+3,648
+26% +$755K
SHW icon
163
Sherwin-Williams
SHW
$78.8B
$3.82M 0.12%
10,009
+1,984
+25% +$692K
ASML icon
164
ASML
ASML
$617B
$3.81M 0.12%
4,570
+557
+14% +$498K
BKR icon
165
Baker Hughes
BKR
$56.4B
$3.8M 0.11%
105,086
+19,453
+23% +$684K
KHC icon
166
The Kraft Heinz Company
KHC
$29.5B
$3.77M 0.11%
107,502
+19,530
+22% +$672K
CL icon
167
Colgate-Palmolive
CL
$69.7B
$3.76M 0.11%
36,203
+7,308
+25% +$745K
EW icon
168
Edwards Lifesciences
EW
$50B
$3.74M 0.11%
56,726
+8,701
+18% +$632K
CVS icon
169
CVS Health
CVS
$120B
$3.72M 0.11%
59,106
+12,180
+26% +$711K
MRVL icon
170
Marvell Technology
MRVL
$209B
$3.68M 0.11%
51,012
+8,757
+21% +$605K
BA icon
171
Boeing
BA
$165B
$3.67M 0.11%
24,164
+4,872
+25% +$835K
XEL icon
172
Xcel Energy
XEL
$45.6B
$3.63M 0.11%
55,611
+9,979
+22% +$592K
EQIX icon
173
Equinix
EQIX
$101B
$3.59M 0.11%
4,048
+812
+25% +$665K
APH icon
174
Amphenol
APH
$192B
$3.59M 0.11%
110,204
+22,736
+26% +$737K
EA
175
DELISTED
Electronic Arts
EA
$3.47M 0.1%
24,161
+4,072
+20% +$590K

Similar funds

NEOS Investment Management's Q3 2024 Portfolio in Review

As of Q3 2024, NEOS Investment Management held 588 positions worth $3.31B, up 36% from $2.43B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

NEOS Investment Management deployed $750M of net new capital in Q3 2024, opening 19 new positions and adding to 513 existing holdings. Its largest new stake was Xtrackers USD High Yield Corporate Bond ETF: 940,956 shares worth $34.6M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 37% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Inari Medical, Inc. Common Stock, an estimated $1.4M trimmed.

  • NEOS Investment Management's largest Q3 2024 buy was Xtrackers USD High Yield Corporate Bond ETF: 940,956 shares worth $34.6M.
  • NEOS Investment Management added most to Vanguard Russell 2000 ETF in Q3 2024, an estimated $62.3M increase.
  • NEOS Investment Management's biggest Q3 2024 reduction was Inari Medical, Inc. Common Stock, cutting an estimated $1.4M.
  • NEOS Investment Management fully exited Super Micro Computer in Q3 2024, selling an estimated $812K.
  • NEOS Investment Management's ten largest holdings make up 34% of its $3.31B portfolio in Q3 2024.
  • NEOS Investment Management opened 19 new positions and closed 9 in Q3 2024.
  • NEOS Investment Management's portfolio value rose 36% quarter-over-quarter to $3.31B.

Based on NEOS Investment Management's 13F filing for Q3 2024, filed 13 Nov 2024.